| Date | Title | Description |
| 28.10.2024 | Be Biopharma: Pioneering the Future of Genetic Medicine with $82 Million in New Funding | In the ever-evolving landscape of biotechnology, Be Biopharma stands out like a lighthouse in a storm. This Cambridge, Massachusetts-based company has just secured $82 million in funding, a financial windfall that promises to propel its inn... |
| 25.10.2024 | Be Bio: $82 Million Raised To Discover And Develop Engineered B Cell Medicines | Be Biopharma – a leader in the discovery and development of engineered B Cell Medicines (BCMs) – announced key milestones alongside a new round of funding as its lead program BE-101 for Hemophilia B, enters the clinic, and its second develo... |
| 23.10.2024 | Be Biopharma Raises $82M in Financing | Be Biopharma, a Cambridge, MA-based company which specializes in the discovery and development of engineered B Cell Medicines (BCMs), raised $82M in funding.
Backers included ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta... |
| 22.10.2024 | HealthEx Raises $14M in Funding | HealthEx’s co-founders: CEO Priyanka Agarwal and CTO Anand Raghavan
HealthEx, a San Francisco, CA-based provider of a global consumer preference and consent platform for healthcare to unlock data access, raised $14M in Seed and Series A fun... |
| 22.10.2024 | Terray Therapeutics: $120 Million (Series B) Secured To Improve Human Health | Terray Therapeutics, a biotechnology company focused on improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation integrated with novel data at scale, announced Series B fu... |
| 20.10.2024 | Monument Therapeutics: Precision Neuroscience Company Raises £1 Million | Monument Therapeutics, a precision neuroscience company, announced a further £1 million equity investment by the Forster Foundation, a charitable incorporated organization. This new funding builds on equity and non-dilutive funding announce... |
| 19.10.2024 | MEDiC Life Sciences: Pioneering Cancer Solutions with $5 Million Boost | In the heart of Silicon Valley, a new force is emerging in the battle against cancer. MEDiC Life Sciences, a functional genomics startup, has secured a strategic investment of $5 million from LG and Hanmi Pharmaceutical. This funding marks ... |
| 18.10.2024 | MEDiC Life Sciences: Functional Genomics Company Raises $5 Million | MEDiC Life Sciences, a leading functional genomics startup in Silicon Valley, announced a $5 million strategic investment from LG and Hanmi Pharmaceutical. This funding comes ahead of MEDiC’s planned Series-A round later this year. Previous... |
| 17.10.2024 | Terray Therapeutics Closes $120M Series B Funding Round | Terray Therapeutics, a Los Angeles, CA-based biotechnology company improving human health by enhancing small molecule drug development, raised $120M in Series B funding.
The round was led by Bedford Ridge Capital and existing investor NVent... |
| 15.10.2024 | MEDiC Life Sciences Raises $5M in Strategic Funding | MEDiC Life Sciences, a Mountain View, CA-based functional genomics startup, raised $5M in strategic funding.
The round was led by LG and Hanmi Pharmaceutical.
The company intends to use the funds to accelerate the adoption of its cancer bio... |
| 13.10.2024 | World Thrombosis Day raises global awareness of blood clot dangers through actionable initiatives | Help shape the future of women's health by taking the survey and supporting this global campaign in its eleventh year to improve care for at-risk patients.
CHAPEL HILL, N.C., Oct. 13, 2024 /PRNewswire/ -- Today is World Thrombosis Day, a gl... |
| 08.10.2024 | RWD to the Rescue: Solving R&D Challenges for Pharma Companies, Upcoming Webinar Hosted by Xtalks | www.trinetx.com
In this free webinar, learn about using real-world data (RWD) to power the design of asset strategies and clinical trials. Attendees will gain insights into leveraging RWD to gain insights into cohorts, endpoints, feasibilit... |
| 04.10.2024 | Jeff Zevely to emcee the 2024 San Diego Miles for Melanoma 5K | Jeff Zevely
The Melanoma Research Foundation (MRF) is thrilled to announce that Jeff Zevely will be returning to emcee the annual Miles for Melanoma San Diego 5K event on Sunday, October 20, 2024 at De Anza Cove Park. Jeff will welcome gues... |
| 02.10.2024 | Owkin Partners with AstraZeneca for Advanced AI gBRCA Pre-Screening | Share
Tweet
Share
Share
Email
Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer.
Takeaway Points Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast canc... |
| 01.10.2024 | Aktis Oncology: $175 Million (Series B) Secured To Develop Targeted Alpha Radiopharmaceuticals For Treating Tumors | Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, announced the successful closing of an oversubscribed and u... |
| 30.09.2024 | Aktis Oncology Raises $175M in Series B Funding | Aktis Oncology, a Boston, MA-based clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, closed a $175m Series B financing.
The rou... |
| 28.09.2024 | Market Momentum: Dow Hits New Heights Amid Easing Inflation | The stock market is a living organism, constantly shifting and adapting. On September 27, 2024, the Dow Jones Industrial Average surged to a record high, propelled by a favorable inflation report. This news was like a gust of wind beneath t... |
| 27.09.2024 | Dow advances to record high after inflation report; small caps outperform | U.S. MarketsDow advances to record high after inflation report; small caps outperform
By Johann M Cherian and Purvi AgarwalSeptember 27, 20244:20 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
... |
| 25.09.2024 | Ученые обнаружили, что заразные формы рака вызваны изменением окружающей среды | У медузоподобных существ, называемых гидрами, при избыточном питании могут развиваться опухоли, которые, в свою очередь, могут передаваться их потомству. Новое исследование, посвященное этому явлению не только раскрыло подробности процесса ... |
| 19.09.2024 | Transcenta Updates Encouraging Efficacy Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ESMO 2024 | Updated results with longer follow-up reveal confirmed ORR of 68% and median PFS of 14.2 months in patients with CLDN18.2 high or medium expression, known PD-L1 CPS (n=66).
PRINCETON, N.J. and SUZHOU, China, Sept. 19, 2024 /PRNewswire/ -- T... |
| 19.09.2024 | Радиофармацевтические препараты назвали прорывом в борьбе с раком | Производители лекарств делают ставку на то, что доставка радиации непосредственно к опухолям станет следующим большим прорывом в борьбе с раком. Bristol Myers Squibb, AstraZeneca, Eli Lilly и другие фармацевтические компании потратили около... |
| 16.09.2024 | Circle Pharma Expands Leadership Team to Drive the Development of Its Pipeline of Oral Macrocycle Therapies | SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–September 16, 2024–
Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced ... |
| 15.09.2024 | Dialogue with CGT Leaders! You Are Invited to Join the "2024 GenScript Biotech Global Forum•London" to Discuss the Future Together | PISCATAWAY, N.J., Sept. 15, 2024 /PRNewswire/ -- The year 2024 marks a milestone year for continuous advancements in Cell and Gene Therapy (CGT). The global launch of Amtagvi, a Tumor-Infiltrating Lymphocyte (TIL) therapy, has ushered in a ... |
| 09.09.2024 | Стартап в сфере клеточной терапии ArsenalBio привлек $325 млн | В раунде финансирования Arsenal Biosciences приняли участие новые инвесторы ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures (венчурное подразделение NVIDIA), Luma Group, фонды, консультируемые T. Rowe Price... |
| 05.09.2024 | Novartis Expands Radioligand Therapy Manufacturing in the U.S. | In a bold move to combat cancer, Novartis is laying the groundwork for two new radioligand therapy (RLT) manufacturing facilities in the United States. This expansion is not just a step; it’s a leap into the future of cancer treatment. With... |
| 04.09.2024 | ArsenalBio: $325 Million (Series C) To Enhance Programmable Cell Therapy Programs | Arsenal Biosciences, a clinical-stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced today the closing of an oversubscribed $325 million Series C financing round.
This fund... |
| 04.09.2024 | Ian Michael Crumm to emcee the 2024 New York Miles for Melanoma 5K | Ian Michael Crumm, 2024 New York Miles for Melanoma 5K event emcee
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patien... |
| 04.09.2024 | Success! Cancer Survivor Julia Brookshire and Olympic Swimmer Janel Jorgensen McArdle Successfully Swim "World's Oldest" Hellespont and Dardanelles Open Water Swim | Julia Brookshire and Janel Jorgensen McArdle at the historic Hellespont and Dardanelles swim on August 30th, celebrating Brookshire’s CLL remission and raising funds for Swim Across America.
Swimmer Friends and Colleagues Completed Swim Aug... |
| 04.09.2024 | ArsenalBio Raises $325M in Series C Funding | ArsenalBio, a San Francisco, CA-based clinical stage programmable cell therapy company, raised $325M in Series C funding.
The round was led by ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures, Luma Group, fu... |
| 03.09.2024 | SKIES ACROSS NORTH AMERICA TO LIGHT UP THIS FALL IN SUPPORT OF BLOOD CANCER PATIENTS | The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support is critical
RYE BROOK, N.Y., Sept. 3, 2024 /PRNewswire/ -- The Leukemia & Lymphom... |
| 03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| 03.09.2024 | ProofPilot Bolsters Advisory Board with Appointment of Michelle Everill | NEW YORK, Sept. 3, 2024 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience, welcomes the addition o... |
| 29.08.2024 | The Future of Pharmaceuticals: Navigating Price Negotiations and Patient Access | The landscape of pharmaceuticals is shifting. The winds of change are blowing through Wall Street and the healthcare system alike. As the U.S. government prepares for drug price negotiations under the Inflation Reduction Act, the stakes are... |
| 29.08.2024 | Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results | 2024 Interim Result Highlights (For the six months ended June 30, 2024)
Company published the efficacy and safety data of Cohort-G of TranStar102 study for osemitamab (TST001), plus checkpoint inhibitor and CAPOX as the first-line treatment... |
| 29.08.2024 | Amidst Exponential AI Growth, Blend Creates Chief Solutions Officer Role- Appoints ex-Accenture Leader | NEW YORK, Aug. 29, 2024 /PRNewswire/ -- Blend, an award-winning AI and Data Science services firm for Fortune 500 companies, is proud to announce the promotion of Rob Fuller to Chief Solutions Officer (CSO). In this pivotal role, Rob will l... |
| 29.08.2024 | Circio Holding ASA: First half 2024 results | Circio Holding ASA: First half 2024 results
Thu, Aug 29, 2024 07:00 CET Report this content
Oslo, Norway, 29 August 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing novel circular RNA gene therapies, today announces... |
| 27.08.2024 | JW Therapeutics Announces NMPA Approval of the Supplemental Biological License Application for Carteyva® in Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma | SHANGHAI, Aug. 27, 2024 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Med... |
| 24.08.2024 | The Rise of RNA Medicines: Borealis Biosciences and the Future of Kidney Disease Treatment | In the world of biotechnology, innovation is the lifeblood. Borealis Biosciences has emerged as a beacon of hope in the treatment of kidney diseases. Recently, the company raised $150 million in Series A financing, marking a significant mil... |
| 23.08.2024 | Ozempic on Wall Street's list for 2027 Medicare drug negotiations | Future of HealthOzempic on Wall Street's list for 2027 Medicare drug negotiations
By Michael ErmanAugust 23, 202412:06 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A box of Ozempic made by No... |
| 22.08.2024 | Trinity Life Sciences Announces New Customer Engagement Solutions | Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform. The new ... |
| 21.08.2024 | Innovations in Financial Planning: A New Era for Later Life Management | In the world of finance, innovation is the lifeblood that keeps the industry vibrant. Recently, two companies emerged as champions in the Later Life Financial Planning Innovation Challenge, hosted by Smart Data Foundry and FinTech Scotland.... |
| 20.08.2024 | Navigating the Future: Snappy Kraken and ModelOp Propel Growth in Financial Services and AI Governance | In the fast-paced world of technology, two companies are making waves: Snappy Kraken and ModelOp. Both are carving out their niches in the financial services and AI governance sectors, respectively. Their recent developments signal a shift ... |
| 20.08.2024 | The Battle for Truth: Navigating the Landscape of Cancer Research and Disinformation | In the realm of cancer research, hope is a beacon. The Society for Immunotherapy of Cancer (SITC) shines that light brightly. Their recent announcement of fellowship recipients is a testament to the commitment to innovation and progress. Wi... |
| 20.08.2024 | REPUBLICA HAVAS EXPANDS NORTH AMERICAN FOOTPRINT WITH THREE APPOINTMENTS | A trio of executives has been appointed to lead the agency's expansion into New York City
NEW YORK, Aug. 20, 2024 /PRNewswire/ - Republica Havas announced today the appointments of three executives to lead the agency's continued expansion i... |
| 20.08.2024 | ModelOp Raises $10 Million to Accelerate the Growth of Its Leading AI Governance Software | Baird Capital leads funding round that will accelerate ModelOp’s market-leading product innovation and enterprise expertise
Related Posts
Stealth AI Startup Rewmo Raises $28 Million Without a Pitch Deck
Aug 21, 2024
Trunk Tools Raises $20 M... |
| 20.08.2024 | ModelOp: AI Governance Company Raises $10 Million (Series B) | ModelOp, a leading AI Governance software for enterprises, announced that it raised $10 million in series B equity funding led by Baird Capital with participation from existing investors.
This funding will be used to expand ModelOp’s team, ... |
| 19.08.2024 | Society for Immunotherapy of Cancer Forward Fund Announces Recipients of Cancer Immunotherapy Fellowships | SITC Logo
In its mission to make "cure" a reality for cancer patients everywhere and support the development of early career investigators, the Society for Immunotherapy of Cancer (SITC) Forward Fund is pleased to announce the rec... |
| 19.08.2024 | ModelOp Raises $10 Million to Accelerate the Growth of Its Leading AI Governance Software | ModelOp is the leading AI Governance software for enterprises and helps safeguard all AI initiatives.
Baird Capital leads funding round that will accelerate ModelOp's market-leading product innovation and enterprise expertise
CHICAGO, Aug. ... |
| 15.08.2024 | Why Authenticity and Patient Voice Are Critical When Driving Clinical Trial Diversity, Upcoming Webinar Hosted by Xtalks | www.jumohealth.com
In this free webinar, gain insights into pursuing grassroots community activation ahead of clinical trial recruitment to build trust with minority and underrepresented communities. Attendees will learn creative ways to we... |
| 15.08.2024 | Health | US drug price measure to cut costs by $7.5 billion in 2026 | Astra said it will accept the price reductions so patients can get its drugs. AbbVie said in a statement that the IRA does nothing to benefit patients and will harm the long-term development of new drugs. Merck and Amgen didn’t immediately ... |
| 12.08.2024 | Roswell Park Indigenous Cancer Screening/Navigation Success Reaches New Mexico with BMS Foundation Grant | The Indigenous Cancer Health team at Roswell Park Comprehensive Cancer Center in Buffalo, NY.
A three-year, $689,000 grant from the Bristol Myers Squibb Foundation will enable Roswell Park's Department of Indigenous Cancer Health and the Un... |
| 03.08.2024 | Johnson Controls: Navigating Change and Growth Amid Leadership Transition | In the world of corporate giants, change is the only constant. Johnson Controls International plc, a leader in smart and sustainable building solutions, is at a pivotal crossroads. Recent announcements reveal a solid financial performance a... |
| 02.08.2024 | Kexing Biopharm's Apexelsin®: A New Dawn in Cancer Treatment | In a significant stride for cancer treatment, Kexing Biopharm has secured European Commission approval for Apexelsin®, a generic version of the well-known drug Abraxane® (Nab-paclitaxel). This approval, announced on July 28, 2024, marks a p... |
| 02.08.2024 | Seasoned chairpersons and board members back life sciences startups |
Anaveon, a clinical-stage company specializing in developing treatments for diseases with immune system dysfunction, focusing on biologics that modulate cytokine functions to provide therapeutic benefit has appointed former Chair and CEO o... |
| 31.07.2024 | JOHNSON CONTROLS ANNOUNCES INITIATION OF CEO SUCCESSION FOLLOWING SIGNIFICANT MILESTONES IN PORTFOLIO TRANSFORMATION | George R. Oliver to retire as CEO and remain chair of the Board, following appointment of successor
Advances Board refreshment with appointment of Patrick Decker as a new, independent director; Appointment follows Constructive Dialogue with... |
| 31.07.2024 | Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval | SHENZHEN, China, July 31, 2024 /PRNewswire/ -- On July 28 2024, Kexing Biopharm announced European Commission approval of Apexelsin®, the generic drug to Bristol Myers Squibb's and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is develope... |
| 31.07.2024 | Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval | SHENZHEN, China, July 31, 2024 /PRNewswire/ -- On July 28 2024, Kexing Biopharm announced European Commission approval of Apexelsin®, the generic drug to Bristol Myers Squibb's and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is develope... |
| 30.07.2024 | The New Frontier in Biotech: Partnerships and Innovations Shaping the Future of Medicine | In the ever-evolving landscape of biotechnology, partnerships are the lifeblood of innovation. Two recent collaborations highlight this trend: GSK's partnership with Flagship Pioneering and Autobahn Therapeutics' successful funding round. B... |
| 29.07.2024 | Predicta Biosciences: Pioneering a New Era in Cancer Diagnostics | Predicta Biosciences is making waves in the ocean of cancer diagnostics. With a fresh infusion of $5.2 million in seed funding, this Boston-based precision oncology company is poised to change the landscape of how we detect and treat blood ... |
| 29.07.2024 | Autobahn Therapeutics: $100 Million Raised To Develop Restorative Treatments For Depression and Other CNS Disorders | Autobahn Therapeutics (a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders) announced the closing of an oversubscribed $100 million Series C funding led by Newpath... |
| 29.07.2024 | Pharma companies less concerned after hearing from US on negotiated prices for Medicare | Boards, Policy & RegulationRegulatory Oversight
Regulatory
Government Health Policy
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
By Patrick Wingrove and Michael ErmanJuly 29, 20245:37 PM UTCUpd... |
| 27.07.2024 | Predicta Biosciences Raises $5.2 Million To Develop Novel Diagnostic And Therapeutic Products | Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, announced it had raised an oversubscribed $5.2 million seed round led by The Engine Ventures. And additional participating investors in... |
| 26.07.2024 | Advancing Dermatological Research: The American Skin Association's 2024 Grants**
** | ** The American Skin Association (ASA) has taken a bold step forward in the fight against skin diseases. On July 22, 2024, the ASA announced its 2024 research grants, a lifeline for scientists dedicated to understanding and treating skin co... |
| 26.07.2024 | BioVaxys and American Skin Association: Pioneering Paths in Medical Research**
** | ** In the ever-evolving landscape of medical research, two organizations stand out: BioVaxys Technology Corp. and the American Skin Association (ASA). Each is carving a niche in their respective fields, focusing on innovative solutions for ... |
| 26.07.2024 | Morning Bid: Stocks on firmer footing after wild week | European MarketsMorning Bid: Stocks on firmer footing after wild week
By ReutersJuly 26, 20244:34 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A general view shows the trading floor at the st... |
| 22.07.2024 | AMERICAN SKIN ASSOCIATION ANNOUNCES 2024 RESEARCH GRANTS FOR SKIN CANCER AND DISEASES | NEW YORK, July 22, 2024 /PRNewswire/ -- American Skin Association has announced the names of the three Investigative Scientist Awards. Andrew Ji, MD of Icahn School of Medicine at Mount Sinai was awarded the ASA Sanofi Investigative Scienti... |
| 15.07.2024 | 16-Year-Old Marathon Swimmer Maya Merhige Successfully Swims the English Channel and Raises More than $100,000 to Fight Cancer | 16-Year-Old Marathon Swimmer Maya Merhige Successfully Swims the English Channel and Raises More than $100,000 to Fight Cancer with Swim Across America.
Berkeley, California, Resident Is Now One of the Youngest in History to Complete the Tr... |
| 10.07.2024 | Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions | CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced additions to its leadership team through key executive appointments and promotions. Today's personnel announcement acco... |
| 10.07.2024 | Frost & Sullivan Institute Honors Global Companies with the Enlightened Growth Leadership Best Practices Recognition, 2024 | SANTA CLARA, Calif., July 10, 2024 /PRNewswire/ -- The Frost & Sullivan Institute is excited to announce the winners of the 2024 Enlightened Growth Leadership Best Practices Recognition from the Americas. This prestigious accolade honor... |
| 27.06.2024 | UltraSight Joins Butterfly Garden to Expand AI Real-Time Guidance Across Point of Care Ultrasound Devices | Leveraging Butterfly Network's platform, UltraSight seeks to enable patients to access cardiac imaging with real-time AI guidance
TEL AVIV, Israel, June 27, 2024 /PRNewswire/ -- Today, UltraSight, a digital health pioneer transforming cardi... |
| 26.06.2024 | Advancing toward a brain on a chip: addressing the need to find therapeutics that work | The webinar included representatives from ACRO Biosystems, Bristol Myers Squibb, and eNuvio
The human brain. It is the most complicated part of the human body. As the control center, this organ is the source of every thought and movement. I... |
| 21.06.2024 | ISTH announces launch of new global education initiative in factor XI/XIa inhibition | Leading international society embarks on multi-year initiative to increase clinician awareness of factor XI/XIa inhibition
BANGKOK, June 21, 2024 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH), the leading wo... |
| 14.06.2024 | OrganoClick appoints Carin Eklund as new CFO | OrganoClick appoints Carin Eklund as new CFO
Fri, Jun 14, 2024 15:51 CET Report this content
OrganoClick has appointed Carin Eklund as the new CFO for the group. She will lead OrganoClick's finance and economics department and be part of th... |
| 13.06.2024 | The Lustgarten Foundation Appoints Two New Board Members | To date, the foundation has invested more than $282M in high-risk, high-reward research to accelerate and expand life-saving treatment options.
Richard Barakat, MD, and Aaron Kantoff join the Lustgarten Foundation Board of Directors
WOODBUR... |
| 11.06.2024 | QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Financial Officer and Appoints Shafique Virani, M.D., to Board of Directors | Industry veteran Williamson brings nearly three decades' experience as a leader in neuroscience R&D at organizations including Eli Lilly and Company, Lundbeck, Parexel, and Acadia Pharmaceuticals
Former Karuna CFO Brown brings more than... |
| 10.06.2024 | Hypertrophic Cardiomyopathy 101: What every student-athlete should know | (Family Features) You may find it difficult to wrap your mind around the idea of an energetic student-athlete with a cardiac diagnosis. Heart conditions may be more often associated with older individuals, but you might be surprised to lear... |
| 05.06.2024 | I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers | I-Mab enters clinical collaboration with Bristol Myers Squibb to evaluate Claudin 18.2 x 4-1BB bispecific antibody givastomig in combination with nivolumab and chemotherapy for the treatment of gastric and esophageal cancer.
Collaboration b... |
| 04.06.2024 | Melissa Seymour to join Lilly as executive vice president of Global Quality | INDIANAPOLIS, June 4, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Melissa Seymour will join the company as executive vice president of Global Quality and member of the company's Executive Committee, effective... |
| 30.05.2024 | US, UK in focus as pharma companies eye $31 billion exports in FY25 | - |
| 30.05.2024 | Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress | SHANGHAI, May 30, 2024 /PRNewswire/ -- JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology company foc... |
| 26.05.2024 | Stress and Skin: A Complex Relationship | Stress can be a silent killer, not just for your mental health but also for your skin. Dermatologists reveal the hidden connection between stress and skin problems, shedding light on how our emotions can manifest physically.
Stress is like ... |
| 24.05.2024 | Kyle Speller to return as Emcee for the 2024 Denver Miles for Melanoma 5K! | Kyle Speller, 2024 Denver Miles for Melanoma 5K event emcee
The Melanoma Research Foundation (MRF) is thrilled to announce that Kyle Speller will be returning to emcee the annual Miles for Melanoma Denver 5K event on Saturday, June 8, 2024 ... |
| 22.05.2024 | NeoPhore Closes Series B Extension Round | Neophore, a Cambridge, UK-based small molecule neoantigen immuno-oncology company, raised an undisclosed amount in Series B extension funding.
Bristol Myers Squibb (NYSE: BMY) made the investment.
The company intends to use the funds to exp... |
| 22.05.2024 | Breakthrough Properties to Welcome Three Mission-Driven Biotech Companies to One Canal Development in the Heart of Cambridge | Leases with Deep Genomics, Larkspur Biosciences and Incendia Therapeutics Executed Upon Substantial Construction Completion, Anchoring Breakthrough's East Cambridge Waterfront Building
BOSTON, May 22, 2024 /PRNewswire/ -- Breakthrough Prope... |
| 21.05.2024 | Taye Diggs wants to "change the conversation" around schizophrenia after sister's diagnosis | Taye Diggs is opening about a mental health condition that has affected his family: schizophrenia.
The actor, 53, revealed for the first time that his younger sister Christian, 48, was diagnosed with the condition in her 20s.
"I didn't... |
| 20.05.2024 | Studies Show Linked Biological Pathways Driving Skin Inflammation | NEW YORK, May 20, 2024 /PRNewswire/ -- A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all inf... |
| 14.05.2024 | Kalderos Appoints Daryl Todd as Chief Strategy Officer | Daryl Todd, Chief Strategy Officer at Kalderos
What You Should Know:
– Kalderos, the data infrastructure and analytics company behind the world’s first Drug Discount Management platform, has appointed Daryl Todd as its new Chief Strategy Of... |
| 03.05.2024 | Patients on hunt for diabetes, obesity and weight-loss drugs | - |
| 01.05.2024 | Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) Announces Launch to Set New Standard in Life Sciences Commercialization Management Consulting | NEW YORK, May 1, 2024 /PRNewswire/ -- Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) is proud to announce its official launch, poised to set a new standard in life sciences consulting. Founded by Sherif Salti, a disting... |
| 01.05.2024 | Raheem Mostert, Miami Dolphins, Melanoma Supporter and Advocate, Gets Naked for Melanoma Awareness Month | #GetNaked Campaign Spokesperson, Raheem Mostert, Miami Dolphins Running Back, melanoma supporter and advocate
The Melanoma Research Foundation (MRF) is pleased to announce the official launch of its annual award-winning #GetNaked campaign i... |
| 01.05.2024 | The New York Jets Go on the Offense at the Lupus Research Alliance 2024 New Jersey "Walk with Us to Cure Lupus" | EAST RUTHERFORD, N.J., May 1, 2024 /PRNewswire/ -- Nearly 1,500 supporters will help tackle lupus this Saturday, May 4, for the Lupus Research Alliance (LRA) 2024 New Jersey Walk with Us to Cure Lupus at MetLife Stadium. Together, the passi... |
| 30.04.2024 | Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO) | SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for... |
| 30.04.2024 | Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic | Fundraising Includes New Strategic Investment by Bristol Myers Squibb along with Continued Support from Existing Investors including Canaan and Brandon Capital
Proceeds to be Used to Advance Lead Candidate, PTT-4256, into the Clinic and Exp... |
| 27.04.2024 | The Melanoma Research Foundation to host the DC Miles for Melanoma 5K | 2024 DC Miles for Melanoma 5K
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thr... |
| 27.04.2024 | India becoming attractive for clinical trials, says pharma industry leaders | - |
| 24.04.2024 | Pharma exports rise around 10% to $27.9 billion, US biggest importer | - |
| 24.04.2024 | Govt expands committee for drugs, medical devices pricing reforms | - |
| 20.04.2024 | The Melanoma Research Foundation to host the New England Miles for Melanoma 5K | New England Miles for Melanoma
The Melanoma Research Foundation (MRF) is thrilled to announce one of the first events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, care partners and thriv... |
| 15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - |
| 11.04.2024 | Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer | SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company dedicated to developing novel medicines to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ... |
